2-[4-chloro-2-(1,1-difluoroethyl)phenyl]-3-[4-[1-(3-fluoropropyl)azetidin-3-yl]oxyphenoxy]-6H-thieno[2,3-e]indazole

ID: ALA5185539

Chembl Id: CHEMBL5185539

PubChem CID: 168278867

Max Phase: Preclinical

Molecular Formula: C29H25ClF3N3O2S

Molecular Weight: 572.05

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(F)(F)c1cc(Cl)ccc1-c1sc2c(ccc3[nH]ncc32)c1Oc1ccc(OC2CN(CCCF)C2)cc1

Standard InChI:  InChI=1S/C29H25ClF3N3O2S/c1-29(32,33)24-13-17(30)3-8-21(24)28-26(22-9-10-25-23(14-34-35-25)27(22)39-28)38-19-6-4-18(5-7-19)37-20-15-36(16-20)12-2-11-31/h3-10,13-14,20H,2,11-12,15-16H2,1H3,(H,34,35)

Standard InChI Key:  ZODICFXFVWCCEB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5185539

    ---

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAMA-1 (145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-361 (612 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 572.05Molecular Weight (Monoisotopic): 571.1308AlogP: 8.42#Rotatable Bonds: 9
Polar Surface Area: 50.38Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.58CX Basic pKa: 6.76CX LogP: 6.57CX LogD: 6.48
Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.19Np Likeness Score: -1.01

References

1. Lu Z, Cao Y, Zhang D, Meng X, Guo B, Kong D, Yang Y..  (2022)  Discovery of Thieno[2,3-e]indazole Derivatives as Novel Oral Selective Estrogen Receptor Degraders with Highly Improved Antitumor Effect and Favorable Druggability.,  65  (7.0): [PMID:35357160] [10.1021/acs.jmedchem.2c00008]

Source